Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): A phase 3 open-label randomised study

  1. Cortes, J.
  2. O'Shaughnessy, J.
  3. Loesch, D.
  4. Blum, J.L.
  5. Vahdat, L.T.
  6. Petrakova, K.
  7. Chollet, P.
  8. Manikas, A.
  9. Diéras, V.
  10. Delozier, T.
  11. Vladimirov, V.
  12. Cardoso, F.
  13. Koh, H.
  14. Bougnoux, P.
  15. Dutcus, C.E.
  16. Seegobin, S.
  17. Mir, D.
  18. Meneses, N.
  19. Wanders, J.
  20. Twelves, C.
Revue:
The Lancet

ISSN: 0140-6736

Année de publication: 2011

Volumen: 377

Número: 9769

Pages: 914-923

Type: Article

DOI: 10.1016/S0140-6736(11)60070-6 GOOGLE SCHOLAR